Abeona Therapeutics Inc (ABEO) Stock Price, Quote, News & History

ABEONASDAQ
$5.94
-0.06-1%
Last update: Sep 8, 9:30 AM

Abeona Therapeutics (ABEO) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-76.44M
Investing Cash Flow (TTM)
-34.42M
Financing Cash Flow (TTM)
3.22M
Free Cash Flow (TTM)
-81.53M
Capital Expenditure (TTM)
-5.09M
Net Change in Cash (TTM)
-107.64M

Analyst Trends and Forecast

2
Mar
1
May
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.4
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$216.15M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
14.60
PB Ratio (TTM)
2.68
Earnings Yield % (TTM)
-20.14%
Earnings Yield % (FWD)
-7.41%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$2.24

Company Debt

Total Debt
$14.99M
LT Debt
$1.66M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$56.23M
Debt to Equity
0.16
Issuance of Debt (TTM)
-$5.56M
Repayment of Debt (TTM)
-

Key Statistics

Open
$5.94
Close
-
Volume / Avg.
230.20K / 1.37M
Day Range
$5.81 - $5.99
52 Wk Range
4.00 - 7.65
Market Cap
$339.67M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
44
Short Interest
26.79%
Days to Cover
6.87

About

Sector
Health Care
Industry
Biotechnology
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene the...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Abeona Therapeutics (ABEO) stock?

A

You can purchase shares of Abeona Therapeutics (NASDAQ:ABEO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Abeona Therapeutics (ABEO) competitors?

Q

What is the forecast, or price target, for Abeona Therapeutics (ABEO) stock?

A

Abeona Therapeutics has a consensus price target of $18.57.

Q

What is the current price for Abeona Therapeutics (ABEO)?

A

The stock price for Abeona Therapeutics (NASDAQ: ABEO) is $5.94 last updated September 8, 2026 at 9:30 AM EDT.

Q

Does Abeona Therapeutics (ABEO) pay a dividend?

A

There are no upcoming dividends for Abeona Therapeutics.

Q

When is Abeona Therapeutics (NASDAQ:ABEO) reporting earnings?

A

Abeona Therapeutics does not have any upcoming earnings scheduled.

Q

Is Abeona Therapeutics (ABEO) going to split?

A

There is no upcoming split for Abeona Therapeutics.

Q

What sector and industry does Abeona Therapeutics (ABEO) operate in?

A

Abeona Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.